Share on StockTwits

Radius Health (NASDAQ:RDUS) will be announcing its Q2 earnings results on Tuesday, August 12th. Analysts expect the company to announce earnings of ($0.89) per share for the quarter.

Shares of Radius Health (NASDAQ:RDUS) opened at 11.81 on Monday. Radius Health has a 1-year low of $7.46 and a 1-year high of $17.32. The stock’s 50-day moving average is $11.23 and its 200-day moving average is $10.55. The company’s market cap is $341.8 million.

Several analysts have recently commented on the stock. Analysts at Cowen and Company initiated coverage on shares of Radius Health in a research note on Wednesday, July 16th. They set an “outperform” rating on the stock. On a related note, analysts at Cantor Fitzgerald initiated coverage on shares of Radius Health in a research note on Wednesday, July 16th. They set a “buy” rating and a $20.00 price target on the stock. Finally, analysts at Canaccord Genuity initiated coverage on shares of Radius Health in a research note on Wednesday, July 16th. They set a “buy” rating and a $21.00 price target on the stock.

Radius Health, Inc is a science-driven biopharmaceutical company focused on developing therapeutics for patients with osteoporosis, as well as other serious endocrine-mediated diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.